2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Assignee

• Blueprint Medicines

Inventors

• Natasja Brooijmans (13 patents)
• Lucian V. DiPietro (25 patents)
• Paul E. Fleming (32 patents)
• Joseph L. Kim (62 patents)
• Steven Mark Wenglowsky (15 patents)
• Yulian Zhang (33 patents)

View full patent text on Google Patents →